Suppr超能文献

土耳其静脉血栓形成患者中凝血因子V莱顿突变、凝血酶原G20210A突变及蛋白C突变的频率

Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.

作者信息

Altinisik Julide, Ates Omer, Ulutin Turgut, Cengiz Mujgan, Buyru Nur

机构信息

Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

出版信息

Clin Appl Thromb Hemost. 2008 Oct;14(4):415-20. doi: 10.1177/1076029607306404. Epub 2007 Dec 26.

Abstract

Several inherited polymorphisms are associated with risk of venous thrombosis, including mutation at codon 506 of the factor V gene, mutation at position 20210 of the prothrombin gene, and mutations in the protein C gene. In this study, genotyping for factor V, prothrombin, and protein C mutations was performed in 50 patients and 25 control subjects by polymerase chain reaction-based analysis. The prevalence of factor V and prothrombin mutations was not significantly different from that in the general population. Nine of the patients had heterozygous protein C mutation. There was a high prevalence of the mutated protein C allele in the pulmonary emboli group (42.8%). Protein C mutation incidence was higher in the pulmonary emboli group than in the deep vein thrombosis (8.33%) and cerebral vein thrombosis (16.1%) groups. These results indicate that patients with protein C deficiency have a greater risk of thrombosis than patients with factor V or prothrombin G20210A mutation.

摘要

几种遗传多态性与静脉血栓形成风险相关,包括凝血因子V基因第506密码子突变、凝血酶原基因第20210位突变以及蛋白C基因的突变。在本研究中,通过基于聚合酶链反应的分析,对50例患者和25例对照受试者进行了凝血因子V、凝血酶原和蛋白C突变的基因分型。凝血因子V和凝血酶原突变的患病率与一般人群无显著差异。9例患者存在杂合子蛋白C突变。肺栓塞组中突变的蛋白C等位基因患病率较高(42.8%)。肺栓塞组的蛋白C突变发生率高于深静脉血栓形成组(8.33%)和脑静脉血栓形成组(16.1%)。这些结果表明,与凝血因子V或凝血酶原G20210A突变患者相比,蛋白C缺乏患者发生血栓形成的风险更大。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验